Timothy Beukelman

Vertex Pharmaceuticals
Boston, United States

Disclosure information not submitted.

Presentation(s):

• Frequency of Vaso-Occlusive Crises Among Patients with Severe Sickle Cell Disease Receiving Standard-of-Care Treatment

  Sunday, August 27, 2023
  8:45 AM – 9:00 AM ADT